Literature DB >> 16823516

Effect of extracellular ATP on the human leukaemic cell line K562 and its multidrug counterpart.

Alcira A Bernardo1, Flavio Eduardo Pinto-Silva, Pedro M Persechini, Robson Coutinho-Silva, José Roberto Meyer-Fernandes, André Luiz Fonseca de Souza, Vivian M Rumjanek.   

Abstract

Extracellular ATP (ATPo) is capable of inducing different events on cells through receptor activation. The effect produced by ATPo was studied in the cell line K562 and its multidrug resistant (MDR) counterpart, Lucena 1. Lower ATPo concentrations (1 mM and 2.5 mM) led to high (3)H-thymidine incorporation but no increase in cell number. Similarly, the cell cycle profile indicated an increase of cells in S phase and a decrease in G1 and G2, suggesting that the cells did not duplicate their DNA content. Higher doses of ATP (5 mM and 10 mM), as well as UTP (5 mM) and the P2X(7) agonist BzATP, were cytotoxic. However, no expression of P2X(7) receptors could be detected by Western Blot nor were the cells permeabilised by ATP, suggesting that pore formation was not involved in cell death. Both ecto-ATPase and ecto-5'-nucleotidase activity could be demonstrated at the surfaces of K562 and Lucena 1 cells, the latter presenting a higher ecto-5'-nucleotidase activity. Adenosine induced cell death at lower concentrations (2.5 mM) on both cell lines. Furthermore, an increased number of dead cells could be observed when 5 mM Adenosine was used compared to the same concentrations of ATPo. It still remains to be elucidated the nature of the receptors involved in the induction of cell death in these cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823516     DOI: 10.1007/s11010-006-9154-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Extracellular ATP shows synergistic enhancement of DNA synthesis when combined with agents that are active in wound healing or as neurotransmitters.

Authors:  D J Wang; N N Huang; L A Heppel
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

Review 2.  Nucleotide receptors: an emerging family of regulatory molecules in blood cells.

Authors:  F Di Virgilio; P Chiozzi; D Ferrari; S Falzoni; J M Sanz; A Morelli; M Torboli; G Bolognesi; O R Baricordi
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

3.  Ecto-5'-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin.

Authors:  P Ujházy; M Klobusická; O Babusíková; P Strausbauch; E Mihich; M J Ehrke
Journal:  Int J Cancer       Date:  1994-10-01       Impact factor: 7.396

4.  ATP, a partial agonist for the P2Z receptor of human lymphocytes.

Authors:  C E Gargett; J E Cornish; J S Wiley
Journal:  Br J Pharmacol       Date:  1997-11       Impact factor: 8.739

5.  P2Z/P2X7 receptor-dependent apoptosis of dendritic cells.

Authors:  R Coutinho-Silva; P M Persechini; R D Bisaggio; J L Perfettini; A C Neto; J M Kanellopoulos; I Motta-Ly; A Dautry-Varsat; D M Ojcius
Journal:  Am J Physiol       Date:  1999-05

6.  P2Z purinoceptor-associated pores induced by extracellular ATP in macrophages and J774 cells.

Authors:  R Coutinho-Silva; P M Persechini
Journal:  Am J Physiol       Date:  1997-12

Review 7.  Trophic actions of extracellular ATP: gene expression profiling by DNA array analysis.

Authors:  J T Neary
Journal:  J Auton Nerv Syst       Date:  2000-07-03

8.  Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance.

Authors:  P Ujházy; E S Berleth; J M Pietkiewicz; H Kitano; J R Skaar; M J Ehrke; E Mihich
Journal:  Int J Cancer       Date:  1996-11-15       Impact factor: 7.396

9.  Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase.

Authors:  Masaru Saitoh; Kaoru Nagai; Kazuhiko Nakagawa; Takehira Yamamura; Satoshi Yamamoto; Tomoyuki Nishizaki
Journal:  Biochem Pharmacol       Date:  2004-05-15       Impact factor: 5.858

10.  The multidrug resistance (mdr1) gene product functions as an ATP channel.

Authors:  E H Abraham; A G Prat; L Gerweck; T Seneveratne; R J Arceci; R Kramer; G Guidotti; H F Cantiello
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more
  4 in total

1.  Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resection.

Authors:  Haiou Liu; Weisi Liu; Zheng Liu; Yidong Liu; Weijuan Zhang; Le Xu; Jiejie Xu
Journal:  Tumour Biol       Date:  2015-02-27

Review 2.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

Review 3.  Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors.

Authors:  Tamás Deli; László Csernoch
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

Review 4.  Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?

Authors:  Vivian M Rumjanek; Raphael S Vidal; Raquel C Maia
Journal:  Biosci Rep       Date:  2013-11-25       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.